Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

10,714 total articles

AMD: AI Demand Reaches Critical Mass - Upgrade to Buy

AMD: AI Demand Reaches Critical Mass - Upgrade to Buy

Advanced Micro Devices looks positioned to ride the next leg of AI infrastructure spending. With a $745.6B market cap, durable free cash flow and near-zero leverage, AMD is expensive on headline multiples but the company’s product mix and hyperscaler momentum argue for further upside. This trade idea presents a mid-term swing (45 trading days) long…

MSCI: A Five-Year Reset Ends — Time to Ride the Next Growth Cycle

MSCI: A Five-Year Reset Ends — Time to Ride the Next Growth Cycle

After a prolonged period of consolidation and an uneven growth cadence, MSCI shows the ingredients for a renewed growth leg: healthy free cash flow, a $41.5B market cap valuation that already prices in premium recurring revenues, improving technicals, and catalytic tailwinds across indices, analytics and ESG. This trade idea lays out an actionable …

Buy Melrose (MLSPF): Trade the Short Pressure, Size Risk Appropriately

Buy Melrose (MLSPF): Trade the Short Pressure, Size Risk Appropriately

Melrose Industries (MLSPF) is showing the technical base and extreme short-side positioning that can produce outsized rebounds. Enter at $6.58 with a tight stop and staged targets. This is a high-risk, high-reward swing trade: favorable reward-to-risk driven by potential rapid short-covering, balanced against OTC liquidity and fundamental opacity.

Fade the Rally in Star Bulk: Short at $31.10, Target $27.50

Fade the Rally in Star Bulk: Short at $31.10, Target $27.50

Star Bulk (SBLK) sits at a 52-week high and is trading well above its 50-day averages after what the market treated as a 'record' quarter. The fundamentals of dry-bulk are cyclical and current prices already reflect robust freight rates and a generous quarterly distribution. This trade idea proposes a tactical short - entry $31.10, stop $32.20, tar…

Comfort Systems (FIX) — Buyable Quality After a Deep Pullback

Comfort Systems (FIX) — Buyable Quality After a Deep Pullback

Comfort Systems USA (FIX) pulled back ~15.6% into $1,640 after a sharp sell-off. The business benefits from the AI data-center buildout, a growing backlog, and strong cash flow generation. Valuation is elevated versus history, but the company’s balance sheet and margin expansion potential provide a reasonable risk/reward for a long trade over the n…

Ryerson Repriced: Olympic Steel’s Move Rewires the Earnings Engine

Ryerson Repriced: Olympic Steel’s Move Rewires the Earnings Engine

Olympic Steel's strategic move has changed the competitive and earnings dynamics for Ryerson (RYI). The market has yet to fully price in the odds of meaningful margin improvement and cash-flow stabilization. This trade idea outlines an actionable long with a clear entry at $18.50, a stop at $14.75, and a target of $26.00 over a mid-term horizon (45…

Loblaw Needs a Repricing - A Mid-Term Short Opportunity

Loblaw Needs a Repricing - A Mid-Term Short Opportunity

Loblaw Companies looks priced for perfection while secular and cyclical pressures are building. We lay out a mid-term short trade with a clear entry at $45.00, stop at $52.50 and a first target at $38.00, explaining the fundamental drivers, catalysts and the scenarios that would change our mind.

AAOI: The AI Hype Is Priced In – A Short Trade Against Perfection

AAOI: The AI Hype Is Priced In – A Short Trade Against Perfection

Applied Optoelectronics (AAOI) has been a poster child for the AI-driven optics rally. The stock's run and a fresh $600M ATM offering on 08/24/2026 suggest the market is pricing near-perfect execution and persistent, margin-rich growth. Fundamentals tell a different story: negative free cash flow, a stretched price-to-sales multiple, and repeated e…

C1s Shakeout Clears Runway for Dianthus: A Tactical Long on DNTH

C1s Shakeout Clears Runway for Dianthus: A Tactical Long on DNTH

Dianthus Therapeutics (DNTH) is a clinical-stage biotech that just experienced a sector-driven sell-off in complement/C1s names. With Phase 3 momentum, sizable recent financings and a concentrated short interest, this pullback presents a tactical long setup. Entry $108.00, stop $95.00, target $150.00 over a mid-term (45 trading days) horizon.